1. Greenstone M, Lasserson TJ. Doxapram for ventila-tory failure due to exacerbations of chronic obstruc-tive pulmonary disease. Cochrane Database of Systematic Reviews. 2002;Issue 2,Art. No.: CD000223. DOI: 0.1002/14651858.CD000223.
2. Angus RM, Ahmed AEA, Fenwick LJ, Peacock AJ. Comparison of the acute affects on gas exchange of nasal ventilation and doxapram in exacerbations of chronic obstructive pulmonary disease. Thorax. 1996;51(10):1048–1050.
3. Newman WJ, Banham SJ, Barr J, et al. A Randomised trial comparing non-invasive ventilation with the respiratory stimulant, doxapram, in the treatment of acute hypercapnic respiratory failure complicating exacerbations of chronic obstructive pulmonary disease. Unpublished data 2001.
4. DRUGDEX® System [database on CD-ROM]. Version 5.1. Greenwood Village, Colo: Thomson Reuters (Healthcare) Inc.
5. Summary of Product Characteristics Dopram® Injec-tion. Anpharm Ltd. March 2001.